Verrica Pharmaceuticals Inc. Active Patents
10 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2023-10-30: Application 18497181; Invention SYNTHESIS OF CANTHARIDIN; Applicant Verrica Pharmaceuticals Inc.; Status Patented Case.
- 2021-09-10: Application 17471853; Invention TREATMENT OF CUTANEOUS DISORDERS; Applicant Verrica Pharmaceuticals Inc.; Status Patented Case.
- 2020-10-20: Application 29755448; Invention AMPULE CRUSH TOOL; Applicant Verrica Pharmaceuticals Inc.; Status Patented Case.
- 2020-09-16: Application 29750763; Invention APPLICATOR; Applicant Verrica Pharmaceuticals Inc.; Status Patented Case.
| Filed | Application | Invention | Applicant | Status | Granted | Patent | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|---|---|
| 2023-10-30 | 18497181 | SYNTHESIS OF CANTHARIDIN | Verrica Pharmaceuticals Inc. | Patented Case | 2025-02-11 | 12221452 | US20240109911A1 | Matthew Gene Davidson Brian Matthew Eklov Peter Wuts Brad Melvin Loertscher Steven R. Schow | United States United States United States United States United States | O DELL, DAVID K |
| 2021-09-10 | 17471853 | TREATMENT OF CUTANEOUS DISORDERS | Verrica Pharmaceuticals Inc. | Patented Case | 2025-02-25 | 12233042 | US20210401793A1 | Howard Welgus Matthew Gene Davidson Jayson Michael Rieger | United States United States United States | RAMACHANDRAN, UMAMAHESWARI |
| 2020-10-20 | 29755448 | AMPULE CRUSH TOOL | Verrica Pharmaceuticals Inc. | Patented Case | 2023-04-11 | D983407 | Eugene R. Scavola Paul Daly Gregory Alcorn Vicki Fluck | United States United States United States United States | KHURSHID, MAHEEN | |
| 2020-09-16 | 29750763 | APPLICATOR | Verrica Pharmaceuticals Inc. | Patented Case | 2024-07-23 | D1036656 | Matthew Gene Davidson Jayson Michael Rieger Eugene Scavola Paul Daly | United States United States United States United States | RODRIGUEZ, HOLLY MAE | |
| 2019-12-12 | 16621854 | DEVICES AND METHODS FOR THE TREATMENT OF BODY SURFACE DISORDERS | Verrica Pharmaceuticals Inc. | Patented Case | 2025-05-06 | 12290651 | US20210138214A1 | Matthew Gene Davidson Jayson Michael Rieger Eugene Scavola Paul Daly Howard Welgus | United States United States United States United States United States | ARBLE, JESSICA R |
| 2019-12-05 | 16619675 | TREATMENT OF CUTANEOUS DISORDERS | Verrica Pharmaceuticals Inc. | Patented Case | 2021-10-19 | 11147790 | US20200155498A1 | Howard Welgus Matthew Gene Davidson Jayson Michael Rieger | United States United States United States | RAMACHANDRAN, UMAMAHESWARI |
| 2017-07-19 | 15544669 | QUANTIFICATION AND PREPARATION OF PHARMACEUTICAL GRADE CANTHARIDIN | Verrica Pharmaceuticals Inc. | Patented Case | 2021-11-09 | 11168091 | US20190031674A1 | Matthew Davidson Garry Southan Steven R. Schow Robert Moore | United States United States United States United States | BERKELEY, EMILY R |
| 2017-06-15 | 29607744 | APPLICATOR | Verrica Pharmaceuticals, Inc. | Patented Case | 2020-10-27 | D900312 | Matthew Gene Davidson Jayson Michael Rieger Eugene Scavola Paul Daly | United States United States United States United States | LAWRENCE, SAMANTHA Q | |
| 2017-06-14 | 15535860 | COMMERCIALLY VIABLE SYNTHESIS OF CANTHARIDIN AND BIOACTIVE CANTHARIDIN DERIVATIVES | Verrica Pharmaceuticals, Inc. | Patented Case | 2020-08-18 | 10745413 | US20190002474A1 | Matthew Davidson Steven R. Schow | United States United States | PAGANO, ALEXANDER R |
| 2016-02-19 | 14913335 | COMPOSITIONS, METHODS AND SYSTEMS FOR THE TREATMENT OF CUTANEOUS DISORDERS | Verrica Pharmaceuticals Inc. | Patented Case | 2021-07-06 | 11052064 | US20160193177A1 | Matthew Gene Davidson | United States | ARBLE, JESSICA R |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |